Index -
P/E -
EPS (ttm) -3.36
Insider Own 5.40%
Shs Outstand 52.88M
Perf Week -4.11%
Market Cap 1.58B
Forward P/E -
EPS next Y -0.77
Insider Trans -5.30%
Shs Float 50.44M
Perf Month -9.64%
Income -176.10M
PEG -
EPS next Q -0.46
Inst Own 95.30%
Short Float / Ratio 5.76% / 7.03
Perf Quarter -20.55%
Sales 280.90M
P/S 5.64
EPS this Y -41.80%
Inst Trans -5.73%
Short Interest 2.90M
Perf Half Y 20.85%
Book/sh 5.44
P/B 5.48
EPS next Y 52.20%
ROA -42.60%
Target Price 39.07
Perf Year 56.80%
Cash/sh 3.33
P/C 8.96
EPS next 5Y -
ROE -52.70%
52W Range 16.78 - 40.00
Perf YTD -9.92%
Dividend -
P/FCF -
EPS past 5Y -25.40%
ROI -59.90%
52W High -27.13%
Beta 0.62
Dividend % -
Quick Ratio 3.30
Sales past 5Y 28.60%
Gross Margin 61.10%
52W Low 73.72%
ATR 1.47
Employees 1546
Current Ratio 3.30
Sales Q/Q 32.10%
Oper. Margin -62.80%
RSI (14) 41.31
Volatility 5.70% 4.70%
Optionable Yes
Debt/Eq 0.03
EPS Q/Q 23.00%
Profit Margin -62.70%
Rel Volume 1.33
Prev Close 29.82
Shortable Yes
LT Debt/Eq 0.01
Earnings May 31 AMC
Payout -
Avg Volume 412.68K
Price 29.15
Recom 1.60
SMA20 -4.07%
SMA50 -6.87%
SMA200 -3.12%
Volume 267,649
Change -2.25%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-12-23 Initiated
Stephens
Overweight
$37
Jan-04-23 Reiterated
Needham
Buy
$35 → $40
Dec-13-22 Upgrade
Citigroup
Neutral → Buy
$40
Dec-09-22 Upgrade
SVB Leerink
Mkt Perform → Outperform
$31 → $34
Oct-13-22 Initiated
DA Davidson
Neutral
$25
Sep-16-22 Initiated
KeyBanc Capital Markets
Overweight
$40
Apr-14-22 Initiated
Guggenheim
Buy
$45
Jan-06-22 Downgrade
SVB Leerink
Outperform → Mkt Perform
$57 → $41
Dec-02-21 Initiated
Jefferies
Buy
$70
Sep-02-21 Reiterated
Needham
Buy
$70 → $81
Aug-27-21 Initiated
Canaccord Genuity
Buy
$81
Jul-13-21 Initiated
JMP Securities
Mkt Outperform
$80
Jun-08-21 Initiated
Berenberg
Buy
$70
Apr-29-21 Resumed
JP Morgan
Overweight
$64
Apr-01-21 Initiated
Robert W. Baird
Outperform
$60
Nov-11-20 Initiated
Stephens
Overweight
$50
Oct-27-20 Initiated
Needham
Buy
$44
Sep-22-20 Initiated
DA Davidson
Buy
$35
Jul-14-20 Initiated
Citigroup
Neutral
May-15-20 Initiated
Guggenheim
Buy
$31
Show Previous Ratings
May-17-23 04:03PM
May-16-23 04:05PM
May-15-23 05:45PM
May-11-23 05:35PM
May-09-23 05:35PM
08:06AM
Loading…
May-07-23 08:06AM
May-04-23 08:25AM
May-02-23 05:15PM
Apr-25-23 04:04PM
Mar-29-23 04:03PM
Mar-27-23 11:33AM
06:21AM
Mar-23-23 07:24AM (Thomson Reuters StreetEvents) -7.74%
Mar-22-23 05:15PM
04:03PM
04:03PM
Loading…
04:03PM
Mar-20-23 04:04PM
Mar-18-23 04:32PM
Mar-17-23 06:50AM
Mar-15-23 04:05PM
Mar-08-23 06:45PM
Feb-27-23 10:34AM
09:31AM
09:27AM
Feb-14-23 12:00PM
Feb-03-23 08:41AM
Feb-02-23 06:38AM
Jan-31-23 04:03PM
Jan-26-23 06:45AM
Jan-20-23 05:18PM
02:25PM
Loading…
Jan-04-23 02:25PM
Dec-14-22 11:20AM
Dec-10-22 08:03AM
Dec-08-22 05:15PM
04:03PM
Nov-16-22 04:41PM
Nov-14-22 05:35PM
Nov-10-22 08:05PM
Nov-09-22 05:35PM
Oct-28-22 04:10PM
Oct-18-22 10:03AM
Sep-23-22 09:55AM
Sep-22-22 04:27PM
Sep-16-22 04:46PM
Sep-07-22 05:15PM
05:00PM (Thomson Reuters StreetEvents)
04:03PM
Aug-15-22 09:45AM
Aug-11-22 08:25AM
Aug-09-22 08:35AM
Jul-29-22 06:50AM
Jul-20-22 06:50AM
Jul-18-22 09:55AM
09:55AM
Jun-30-22 09:55AM
Jun-22-22 06:50AM
Jun-07-22 06:45AM
Jun-02-22 05:25PM
04:03PM
May-26-22 04:05PM
03:00PM
May-24-22 06:45AM
May-19-22 06:45AM
May-17-22 05:25PM
04:00PM
May-13-22 07:38AM
May-11-22 05:55PM
09:54AM
May-09-22 08:55AM
Apr-29-22 06:30AM
Apr-25-22 11:10AM (Yahoo Finance Video) +7.25%
09:57AM
08:05AM
Apr-20-22 04:26PM
11:28AM
Mar-31-22 04:15PM
Mar-30-22 05:15PM
04:02PM
Mar-29-22 06:35PM
Mar-17-22 03:52AM
Mar-01-22 06:35PM
Feb-28-22 04:33PM
Feb-08-22 04:05PM
Feb-01-22 05:38PM
Jan-28-22 06:55AM
Jan-27-22 01:38PM
Jan-26-22 08:00AM
Jan-20-22 08:30AM
Jan-18-22 04:15PM
Dec-17-21 11:52AM
Dec-15-21 06:09PM (American City Business Journals)
Dec-13-21 08:30AM
Dec-10-21 09:42AM
Dec-09-21 07:00PM
02:34AM
Dec-08-21 04:05PM
Dec-06-21 07:44AM
Dec-01-21 03:00PM
Nov-29-21 09:40AM
Nov-03-21 11:29AM
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Wilmington, Delaware.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Munson Gillian Director May 10 Sale 30.06 3,555 106,864 19,315 May 11 04:48 PM Indig Chaim Chief Executive Officer May 09 Option Exercise 8.03 12,453 99,998 1,243,675 May 11 04:42 PM Davidoff Michael J. SVP, Payer Business Apr 21 Sale 33.13 1,075 35,615 95,773 Apr 25 05:04 PM Roberts Evan Chief Operating Officer Apr 18 Sale 32.09 7,452 239,167 716,960 Apr 20 04:15 PM VanDuyn Amy Beth SVP, Human Resources Apr 17 Option Exercise 0.84 21,387 17,965 120,005 Apr 18 04:53 PM Roberts Evan Chief Operating Officer Apr 17 Sale 32.01 2,600 83,229 724,412 Apr 18 04:52 PM Gandhi Balaji Chief Financial Officer Apr 17 Sale 31.83 2,113 67,248 85,738 Apr 18 04:53 PM VanDuyn Amy Beth SVP, Human Resources Apr 17 Sale 31.84 570 18,149 119,435 Apr 18 04:53 PM Hoffman Allison C General Counsel & Secretary Apr 14 Sale 31.16 3,306 103,017 128,335 Apr 18 04:52 PM Roberts Evan Chief Operating Officer Apr 12 Sale 32.01 200 6,402 728,793 Apr 13 04:11 PM Davidoff Michael J. SVP, Payer Business Apr 11 Sale 30.91 3,466 107,124 97,971 Apr 12 05:14 PM Smith Mark Douglas Director Apr 03 Option Exercise 4.71 7,000 32,970 23,112 Apr 05 04:36 PM Smith Mark Douglas Director Apr 03 Sale 30.77 7,000 215,367 16,112 Apr 05 04:36 PM VanDuyn Amy Beth SVP, Human Resources Apr 03 Sale 30.79 2,978 91,697 96,481 Apr 05 04:36 PM Linetsky David SVP, Life Sciences Feb 02 Sale 39.55 11,378 449,989 205,489 Feb 06 04:32 PM Davidoff Michael J. SVP, Payer Business Feb 02 Sale 39.21 7,513 294,564 97,971 Feb 06 04:22 PM Rasmussen Randy Chief Financial Officer Feb 02 Sale 40.00 4,765 190,600 145,594 Feb 06 04:34 PM VanDuyn Amy Beth SVP, Human Resources Feb 02 Sale 40.00 300 12,000 99,459 Feb 06 04:29 PM Davidoff Michael J. SVP, Payer Business Jan 31 Sale 38.00 3,265 124,082 105,484 Jan 31 07:08 PM Davidoff Michael J. SVP, Payer Business Jan 30 Option Exercise 7.83 12,090 94,719 137,304 Jan 31 07:08 PM Davidoff Michael J. SVP, Payer Business Jan 30 Sale 36.10 28,555 1,030,790 108,749 Jan 31 07:08 PM Hoffman Allison C General Counsel & Secretary Jan 18 Sale 36.07 649 23,407 129,507 Jan 20 04:36 PM Roberts Evan Chief Operating Officer Jan 03 Sale 31.36 10,000 313,552 703,702 Jan 05 04:36 PM VanDuyn Amy Beth SVP, Human Resources Dec 20 Option Exercise 0.84 15,000 12,600 87,427 Dec 21 04:11 PM VanDuyn Amy Beth SVP, Human Resources Dec 20 Sale 33.73 378 12,750 87,049 Dec 21 04:11 PM Hoffman Allison C General Counsel & Secretary Dec 14 Sale 36.00 801 28,836 102,262 Dec 15 04:57 PM Linetsky David SVP, Life Sciences Dec 13 Sale 34.61 11,377 393,755 185,485 Dec 15 04:54 PM Hoffman Allison C General Counsel & Secretary Dec 13 Sale 34.40 3,109 106,950 103,063 Dec 15 04:57 PM Rasmussen Randy Chief Financial Officer Dec 12 Sale 31.77 7,395 234,913 108,539 Dec 13 04:28 PM Linetsky David SVP, Life Sciences Dec 09 Sale 29.77 26,837 799,072 196,862 Dec 13 04:30 PM Rasmussen Randy Chief Financial Officer Dec 09 Sale 30.39 9,934 301,852 115,934 Dec 13 04:28 PM VanDuyn Amy Beth SVP, Human Resources Nov 02 Sale 26.83 19,341 518,958 72,427 Nov 04 04:11 PM Davidoff Michael J. SVP, Payer Business Oct 18 Sale 25.26 1,075 27,154 106,114 Oct 19 06:14 PM Davidoff Michael J. SVP, Payer Business Sep 16 Sale 27.60 1,296 35,773 108,312 Sep 19 04:39 PM Hoffman Allison C General Counsel & Secretary Sep 15 Sale 28.58 1,290 36,866 107,300 Sep 19 04:39 PM Davidoff Michael J. SVP, Payer Business Jul 21 Sale 25.00 1,404 35,100 108,312 Jul 25 04:11 PM Munson Gillian Director Jul 11 Sale 25.59 2,605 66,656 21,550 Jul 13 04:08 PM VanDuyn Amy Beth SVP, Human Resources Jul 07 Option Exercise 0.84 20,000 16,800 91,983 Jul 11 04:23 PM Davidoff Michael J. SVP, Payer Business Jun 24 Sale 25.11 5,046 126,705 110,509 Jun 28 05:56 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite